Compare DYAI & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYAI | MYND |
|---|---|---|
| Founded | 1979 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 17.9M |
| IPO Year | 2026 | 2017 |
| Metric | DYAI | MYND |
|---|---|---|
| Price | $0.44 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 179.7K | ★ 194.6K |
| Earning Date | 11-11-2026 | 08-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,090,345.00 | N/A |
| Revenue This Year | $113.16 | N/A |
| Revenue Next Year | $94.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $0.26 |
| 52 Week High | $1.60 | $0.89 |
| Indicator | DYAI | MYND |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 37.66 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.50 | $0.35 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 56.77 | 18.12 |
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Mynd.ai Inc provides world'wide, end-to-end, learning solutions and collaboration tools to help teachers, schools, students, and professionals realize their greatest potential. The company has single reporting segment. The company has presence in United States and Rest of world. The company generates majority of revenue from United States.